Bactolife A/S clinical trials
The registry lists 5 studies whose lead sponsor is Bactolife A/S. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 4, 2026.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 5studies on the registry
- 3open to participants now
- 5reach primary completion within a year
Get an email when these change. Save the Bactolife A/S studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Coming up
5 of Bactolife A/S’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.
Phase 3 Other phases
- NNov ’26’26
- 1DDec
- 1JJan ’27’27
- FFeb
- 1MMar
- AApr
- MMay
- JJun
- JJul
- AAug
- 1SSep
- 1OOct
- NNov
All 5
- Dec 2026Safety and User Experience of BP-CBBNCT07628608
- Jan 2027C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.NCT07250724
- Mar 2027Safety and Tolerability Evaluation of BP-LTNCT07819695
- Sep 2027Safety and Tolerability Evaluation of IgG Binding Protein LTNCT07824011
- Oct 2027IgG Binding Protein LT in Support of a Healthy Gut on the GoNCT07873957
Add all 5 to your calendar (.ics) → With an account.
What changed recently
From the registry's own updates since Oct 14, 2026.
Started recruiting3
- Safety and Tolerability Evaluation of BP-LTNov 4, 2026NCT07819695
- IgG Binding Protein LT in Support of a Healthy Gut on the GoOct 20, 2026NCT07873957
- Safety and Tolerability Evaluation of IgG Binding Protein LTOct 16, 2026NCT07824011
Newly registered1
- IgG Binding Protein LT in Support of a Healthy Gut on the GoOct 14, 2026NCT07873957
All 5 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Bactolife A/S.
- Bactolife A/S5 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 5 of 5.
- Safety and Tolerability Evaluation of BP-LTRecruitingNCT07819695Not applicable
- IgG Binding Protein LT in Support of a Healthy Gut on the GoRecruitingNCT07873957Not applicable
- Safety and Tolerability Evaluation of IgG Binding Protein LTRecruitingNCT07824011Not applicable
- C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.Active, not recruitingNCT07250724
- Safety and User Experience of BP-CBBActive, not recruitingNCT07628608Not applicable